AI and Healthcare Transformation Drive Robust Growth in the U.S. Medical Sector

Across the U.S. healthcare landscape, organizations face accelerating demand for innovative treatments and AI-driven solutions that improve patient outcomes while scaling operations. At the forefront of this evolution is a rapidly expanding market fueled by rising healthcare expenditures, digital adoption, and a growing focus on preventative and personalized medicine. Yet, despite robust growth, the sector must still address challenges such as workforce shortages, healthcare access disparities, and evolving regulatory standards—requiring strategic leadership and agility.

In this context, Lingling Tan, Chief Business Officer at Jijia Healthcare USA and Globee Awards Disruptors Judge, has led breakthrough initiatives redefining healthcare delivery and procurement. At L’Oréal’s SkinCeuticals, she established a department focused on medical channel clients, growing the medical division’s contribution from 9% to 44% while expanding omnichannel sales to 18%. These experiences positioned her to drive transformative healthcare initiatives bridging innovation, patient access, and operational scale.

Accelerating Innovation through AI and Collaborative Evidence

Globally, AI is reshaping healthcare, with the market projected to grow from USD 26.57 billion in 2024 to USD 187.69 billion by 2030, at a CAGR of 38.62%. The U.S. AI healthcare market alone is expected to grow from USD 13.26 billion in 2024 to USD 221.09 billion by 2030, at a CAGR of 36.76%. This surge is propelled by advanced digital health infrastructure, the rising prevalence of chronic diseases, supportive government initiatives, and the growing demand for personalized and remote care solutions.

As Lingling Tan, a judge at the Business Intelligence Group, explains, “AI isn’t just a tool; it’s transforming how we approach diagnostics and patient care—bringing greater precision and faster insights that ultimately save lives.” Her paper, "AI-Driven Innovation For A Sustainable Future: Transforming Healthcare", explores ethical AI applications enhancing diagnostics, efficiency, and patient satisfaction. Her collaborations with dermatology committees, including publishing nationwide-recognized protocols in the JEADV, highlight her role in advancing clinical standards and innovation.

Transforming Healthcare Procurement and Growth in the U.S. Market

The healthcare supply chain management market in North America—holding nearly 49% of global share in 2024—is projected to expand from USD 3.93 billion in 2025 to USD 9.53 billion by 2032, growing at a CAGR of 13.5%. This growth is driven by hospitals and health systems adopting cost-cutting strategies and deploying agile procurement systems to manage medical product flow efficiently while reducing waste and errors.

At Jijia Healthcare USA, Lingling Tan serves as Chief Business Officer, leading modernization of procurement across U.S. hospitals. Backed by a $1.3 million early-stage investment, she has spearheaded scalable technology solutions to streamline supply chains, improve reliability, and strengthen operational performance. These initiatives have unlocked multimillion-dollar revenue growth while enabling clinicians to focus more on patient care. Tan emphasizes, “The key to improving healthcare delivery lies in streamlining procurement—from sourcing to supply chain—so clinicians can focus on what matters most: patient care.” Beyond technology deployment, she has built national sales strategies, forged strategic partnerships, and navigated regulatory complexities to sustain growth in a competitive healthcare environment.

Mastering Strategic Growth in the U.S. Healthcare Ecosystem

The U.S. healthcare market continues to expand, with rising demand for chronic disease management, preventative care, and technology-driven treatments. Non-invasive diagnostics, digital therapeutics, and advanced medical devices are gaining traction thanks to lower risk, minimal recovery time, and convenience, appealing to a broad patient demographic.

Aging populations, FDA approvals for new digital health solutions, and the influence of consumer expectations are accelerating adoption. Reflecting on this trajectory, Tan underscores, “Patients want accessible, effective care delivered with efficiency and precision. Technology is the bridge that makes this possible.”

Her leadership at both SkinCeuticals and Jijia Healthcare demonstrates mastery in aligning with these healthcare dynamics. By driving strategic partnerships, pioneering AI integration, and modernizing procurement, she has established herself as a foremost leader advancing sustainable growth in the U.S. healthcare market.